MEDICAPS

MEDICAPS

Small Cap BSE: 523144 NSE: MEDICAPS
₹45.95
0.95 (2.11%)
As on 01 July, 2022 | 06:56

Medicaps Share Price

Medicaps Share Returns

  • Over 1 Month -10.98%
  • Over 3 Month -7.63%
  • Over 6 Month -5.32%
  • Over 1 Year 9.27%

Medicaps Key Statistics

P/E Ratio -1476.7
PEG Ratio -0.6
Market Cap Cr 57.3
Price to Book Ratio 49.2
EPS 0
Dividend 0
Relative Strength Index 39.94
Money Flow Index 25.89
MACD Signal -1.79
Average True Range 3.44
MediCaps Financials
  • Indicator
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev
    Qtr Cr
  • 0.00
  • 0.00
  • 0.00
  • 0.00
  • 0.00
  • Operating Expenses
    Qtr Cr
  • 0.07
  • 0.35
  • 0.07
  • 0.08
  • 0.00
  • Operating Profit
    Qtr Cr
  • -0.07
  • -0.35
  • -0.07
  • -0.08
  • 0.00
  • Depreciation
    Qtr Cr
  • -0.07
  • 0.05
  • 0.05
  • 0.05
  • 0.00
  • Interest
    Qtr Cr
  • 0.00
  • 0.00
  • 0.00
  • 0.00
  • 0.00
  • Tax
    Qtr Cr
  • 0.01
  • 0.00
  • 0.00
  • 0.00
  • -0.01
  • Net Profit
    Qtr Cr
  • 0.17
  • 0.00
  • -0.15
  • -0.05
  • 0.30

Medicaps Technicals

EMA & SMA

Current Price
45.4
0.4 (0.89%)
  • Bullish Moving Average
  • ___
  • 2
  • Bearish Moving Average
  • ___
  • 14
  • 20 Day
  • 47
  • 50 Day
  • 49.63
  • 100 Day
  • 50.68
  • 200 Day
  • 51.02
  • 20 Day
  • 47.32
  • 50 Day
  • 50.72
  • 100 Day
  • 52.55
  • 200 Day
  • 51.07

Medicaps Resistance and Support

PIVOT
₹45.1
Resistance
  • First Resistance
  • 47.6
  • Second Resistance
  • 50.2
  • Third Resistance
  • 52.7
Support
  • First Resistance
  • 42.5
  • Second Resistance
  • 40
  • Third Resistance
  • 37.4
  • RSI
  • 39.94
  • MFI
  • 25.89
  • MACD Single Line
  • -1.79
  • MACD
  • -1.74

Medicaps Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 4,397
  • 293,412
  • 66.73
  • Week
  • 7,546
  • 554,692
  • 73.51
  • 1 Month
  • 5,941
  • 456,510
  • 76.84
  • 6 Month
  • 37,616
  • 2,810,317
  • 74.71

Medicaps Result Highlights

Medicaps Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Medicaps Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-05-25
  • Audited & Quarterly Results
  • 2022-02-10
  • Quarterly Results
  • 2021-11-10
  • Quarterly Results
  • 2021-08-12
  • Quarterly Results
  • 2021-06-24
  • Audited Results

MediCaps Similar Stocks

Company Name
Windlas Biotech Ltd
  • 52 week
  • 452.10
  • Market price
  • 217.80 (-1.00%)
  • Volume
  • 646
  • 52 week
  • 1,917.00
  • Market price
  • 1,500.00 (0.14%)
  • Volume
  • 914
  • 52 week
  • 5.87
  • Market price
  • 4.90 (4.93%)
  • Volume
  • 19839
  • 52 week
  • 3,013.00
  • Market price
  • 1,660.00 (-0.19%)
  • Volume
  • 15968

Medicaps News

MEDI-CAPS LTD.-$ - 523144 - Closure of Trading Window

Pursuant to SEBI (Prohibition of Insider Trading) Regulation, 2015 as amended from time to time read with BSE circular No. LIST/COMP/01/2019-20 dated 2nd April, 2019, the window for trading in the shares of the Company shall remain closed from 1st July, 2022 till completion of 48 hours after the declaration of the Un-Audited Standalone and Consolidated Financial Results for the quarter ended on 30th June, 2022 to the Stock Exchange. All the Directors, KMP's, Designated Employees, Connected Persons, Fiduciaries and their immediate relatives are advised not to deal in the shares of the Company either directly or indirectly during the aforesaid period. The date of meeting of the Board of Directors to approve the Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter ended on 30th June, 2022 shall be informed in due course. You are requested to please take on record above said information for your reference.

MEDI-CAPS LTD.-$ - 523144 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), For The Half Year Ended 31St March, 2022.

Pursuant to Regulation 23(9) of the Listing Regulations as amended from time to time and SEBI Circular No. SEBIIHO/CFD/CMD IICIRlP12021/662 dated November 22, 2021, we are pleased to submit the disclosure of Related Party Transactions for the half year ended 31st March, 2022 in Annexure- I. We will file the same in XBRL mode also within the stipulated time period. You are requested to please take on record our above said information for your reference and record.

MEDI-CAPS LTD.-$ - 523144 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 30 read with Schedule III Part A(A) and in compliance of Regulation 47(1)(a) of SEBI (LODR) Regulations, 2015 regarding extract of Standalone and Consolidated Audited Financial Results for the quarter and year ended on 31st March, 2022 which was approved by the Board in their 01/2022-2023 Board Meeting held on Wednesday, 25th May, 2022 at the Corporate Office of the Company situated at 201, Pushpratna Paradise 9/5 New Palasiya, Opposite UCO Bank Indore (M.P.) 452001. We have herewith enclosed the newspaper advertisement published on 27th May, 2022 in Free Press Journal English edition and Choutha Sansar Hindi edition. You are requested to please take on record our above said information for your reference and records.

MEDI-CAPS LTD.-$ - 523144 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Pursuant to Regulation 24A of the SEBI (LODR) Regulations read with the SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8th February, 2019, please find enclosed herewith the Annual Secretarial Compliance Report of the Company for the year ended 31st March, 2022 issued by M/s. L N Joshi & Company, Practicing Company Secretaries. You are requested to please take on record the above said document for your reference & further needful.

MEDI-CAPS LTD.-$ - 523144 - Submission Of Standalone And Consolidated Audited Financial Results Of The Company As Per Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Quarter As Well As Year Ended On 31St March, 2022.

This is in Continuation of our letter no. MCL/BM/SE/2022-2023 dated 17th May, 2022 regarding information of Board Meeting for consideration and approval of Audited standalone and consolidated Financial Results for the Quarter as well as Financial year ended 31st March, 2022. Pursuant to provisions of the Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby enclosing the Standalone and Consolidated Audited Financial Results of the Company for the Quarter as well as Financial year ended on 31st March, 2022 duly approved by the Board of Directors of the Company at its meeting held on today i.e. Wednesday, 25th May, 2022 together with Auditors Report thereon, Statement of assets and liabilities, cash flow statement and declaration by the Managing Director & Chief Financial Officer of the Company pursuant to second proviso of Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

MediCaps FAQs

What is Share Price of MediCaps ?

MediCaps share price is ₹45 As on 01 July, 2022 | 06:42

What is the Market Cap of MediCaps ?

The Market Cap of MediCaps is ₹57.3 As on 01 July, 2022 | 06:42

What is the P/E ratio of MediCaps ?

The P/E ratio of MediCaps is 5.7 As on 01 July, 2022 | 06:42

What is the PB ratio of MediCaps ?

The PB ratio of MediCaps is 0.5 As on 01 July, 2022 | 06:42